Robust manufacturable controller and miniaturized electronics for Total Artificial Hearts
| Reference number | |
| Coordinator | Scandinavian Real Heart AB |
| Funding from Vinnova | SEK 4 000 000 |
| Project duration | July 2024 - June 2026 |
| Status | Completed |
| Venture | The strategic innovation programme Electronic Components and Systems: |
| Call | Electronic components & systems - research and innovation projects 2024 |
Important results from the project
The project achieved most of its objectives and strengthened the development of next-generation artificial hearts. Through simulations and tests, knowledge about physiological control, higher heart rates and future miniaturization was increased. The project resulted in scientific publications, international knowledge dissemination and deeper collaborations between industry, academia and healthcare. The results form an important basis for continued development and future clinical studies.
Expected long term effects
The project is expected to contribute to the development of safer and more physiologically controlled artificial hearts and create conditions for future clinical studies. The results strengthen the possibilities of developing smaller systems that can suit more patients. The project has also strengthened the collaboration between industry, academia and healthcare and contributed to long-term competence building within Swedish medical technology.
Approach and implementation
The project was carried out through close collaboration between Scandinavian Real Heart and KTH. Regular project meetings were used to plan activities, review results and coordinate publications and conference contributions. Realheart developed and adapted the product while KTH further developed the test environment. The parties collaborated on test setups, conducted experiments together, analyzed data and communicated the results jointly. The project essentially followed the planned direction.